Skip to main content
NUTX $162.64 +0.33%
NUTX logo
NUTX · Nutex Health Inc.
Track NUTX — free
$162.64 +0.54 (+0.33%) At close · Nov 20 Q1 2026 earnings call transcript
Market Cap
$1.12B
Shares
6.86M
Volume · Nov 20 157.56K Avg daily vol (3M) 149.54K
All webcasts

Earnings call · FY2026 Q3

Nutex Health Inc. (NUTX) Q3 2026 Earnings Call

Concluded Nov 6, 2026
Nov 6, 2026
Period
FY2026 Q3
Runtime
—
Sources
2 artifacts
Revenue $217.61M -18.7% YoY
Diluted EPS $5.71 -26.4% YoY
Gross margin 46.7% -11.1 pp YoY
Net income $40.23M -27.4% YoY
Open full screen 8-K 10-Q

Executive readout · one minute

What the filings say

8-K earnings release · filed Nov 5, 2026
Nutex Health reported nine-month 2026 revenue of $644.9 million, down 10.9%, while net income attributable to Nutex Health rose 159% to $152.9 million and operating cash flow reached $188.1 million.
10-Q report · filed Nov 5, 2026
Nutex Health’s arbitration costs totaled $27.8 million for the three months ended September 30, 2026 and $61.4 million for the nine months ended September 30, 2026, compared with $41.9 million and $116.2 million, respectively, in 2025.

The audio replay and transcript follow the call.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Hospital Division$209.10M -19.7% YoY
Population Health Management Division$8.52M +12.6% YoY

Capital returned

Buybacks · derived
$1,000
Shares repurchased
Dividend / share
$2.00
Full-screen source Call document